Ritonavir
What's New
Last Posted: Feb 16, 2021
- Pharmacogenomics of COVID-19 therapies.
Takahashi Takuto et al. NPJ genomic medicine 2020 Aug 5(1) 35 - Pharmacogenomics landscape of COVID-19 therapy response in Serbian population and comparison with worldwide populations.
Stankovic Biljana, et al. Journal of medical biochemistry 2020 10 (4) 488-499 - Pharmacogenomics of COVID-19 therapies
T Takahashi et al, NPJ Genomic Medicine, August 18, 2020 - Impact of IL28B gene polymorphism on efficacy and safety of direct acting antivirals in hepatitis C Egyptian patients.
Ebid Abdel-Hameed Ibrahim Mohamed, et al. International journal of clinical pharmacy 2020 7 - Influence of CYP3A5 and SLCO1B1 polymorphisms on atazanavir/r concentrations in Thai HIV-infected patients.
Singkham Noppaket et al. Pharmacogenomics 2019 20(7) 517-527 - Pharmacogenetic interactions between antiretroviral drugs and vaginally administered hormonal contraceptives.
Haas David W, et al. Pharmacogenetics and genomics 2020 2 - Population pharmacokinetics and pharmacogenetics of ritonavir-boosted darunavir in the presence of raltegravir or tenofovir disoproxil fumarate/emtricitabine in HIV-infected adults and the relationship with virological response: a sub-study of the NEAT001/ANRS143 randomized trial.
Dickinson Laura, et al. The Journal of antimicrobial chemotherapy 2019 11 - Efficacy and safety of ombitasvir/paritaprevir/ritonavir in dialysis patients with genotype 1b chronic hepatitis C.
Atsukawa Masanori, et al. Hepatology research : the official journal of the Japan Society of Hepatology 2017 12 (13) 1429-1437 - Pharmacogenetics-based population pharmacokinetic analysis of tenofovir in Thai HIV-infected patients.
Rungtivasuwan Kanokrat, et al. Pharmacogenomics 2017 11 (16) 1481-1490 - Evaluation of Concomitant Antiretrovirals and CYP2C9/CYP2C19 Polymorphisms on the Pharmacokinetics of Etravirine.
Green Bruce, et al. Clinical pharmacokinetics 2017 0 (5) 525-536
More
About PGx PHGKB
PGx PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other materials that address the translation of genomic and other precision health discoveries into improved health care and prevention related to medications....more
Content Summary
Common PGx Related Topics
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Oct 1, 2020
- Page last updated:Apr 26, 2021
- Content source: